Shingo Shimada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shingo Shimada has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Akinobu Taketomi
Department of Gastroenterological Surgery I Hokkaido University Graduate School of Medicine Sapporo Japan
13 shared publications - Toshiya Kamiyama
Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan
9 shared publications - Hirofumi Kamachi
Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan
8 shared publications Tatsuya Orimo
Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg, Sapporo, Hokkaido 0608638, Japan
8 shared publicationsToshiya Kamiyama
Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg, Sapporo, Hokkaido 0608638, Japan
8 shared publicationsAkihisa Nagatsu
Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg, Sapporo, Hokkaido 0608638, Japan
7 shared publications
Latest Publications
- Open Access
Preoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma
Background/Objectives: The impact of preoperative zinc (Zn) status on the survival and recurrence of patients with hepatocellular carcinoma (HCC) after hepatectomy remains unclear. This study aimed to clarify whether preoperative Zn deficiency affects the prognosis of patients with HCC undergoing initial curative hepatectomy. Methods: We retrospectively reviewed 105 patients who underwent initial curative hepatectomy for HCC at our institution (2011–2018). Preoperative Zn deficiency was defined as serum Zn < 70 µg/dL. Clinical and tumor parameters were compared between patients with and without Zn deficiency. Disease-free and overall survival were evaluated using the Kaplan–Meier method, and prognostic factors were identified via univariate and multivariate Cox proportional hazards analyses. Subgroup analyses were conducted based on age, gender, and etiology. Results: Among 105 patients, 46 (43.8%) showed Zn deficiency (Zn deficiency group), whereas 59 (56.2%) showed normal Zn (normal Zn group). Compared with the normal-Zn group, the Zn deficiency group showed significantly lower hemoglobin, prothrombin activity, serum albumin, and smaller tumor size (all p < 0.05). The Zn deficiency group experienced significantly worse disease-free survival (p = 0.015) but no difference in overall survival (p = 0.63). On multivariate analysis, zinc deficiency (hazard ratio [HR] 1.83, p = 0.040) and prothrombin activity (HR 0.98, p = 0.042) were independent predictors of worse disease-free survival. Subgroup analysis revealed that Zn deficiency was significantly associated with elevated recurrence risk in patients with HCV-related liver disease (HR 3.67, p = 0.013). Conclusions: Preoperative Zn deficiency is an independent predictor of worse DFS after curative hepatectomy. Although further large-scale studies are required to confirm these findings, evaluating preoperative Zn status may help identify patients at high risk of HCC recurrence.
Open AccessPreoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma
Background/Objectives: The impact of preoperative zinc (Zn) status on the survival and recurrence of patients with hepatocellular carcinoma (HCC) after hepatectomy remains unclear. This study aimed to clarify whether preoperative Zn deficiency affects the prognosis of patients with HCC undergoing initial curative hepatectomy. Methods: We retrospectively reviewed 105 patients who underwent initial curative hepatectomy for HCC at our institution (2011–2018). Preoperative Zn deficiency was defined as serum Zn < 70 µg/dL. Clinical and tumor parameters were compared between patients with and without Zn deficiency. Disease-free and overall survival were evaluated using the Kaplan–Meier method, and prognostic factors were identified via univariate and multivariate Cox proportional hazards analyses. Subgroup analyses were conducted based on age, gender, and etiology. Results: Among 105 patients, 46 (43.8%) showed Zn deficiency (Zn deficiency group), whereas 59 (56.2%) showed normal Zn (normal Zn group). Compared with the normal-Zn group, the Zn deficiency group showed significantly lower hemoglobin, prothrombin activity, serum albumin, and smaller tumor size (all p < 0.05). The Zn deficiency group experienced significantly worse disease-free survival (p = 0.015) but no difference in overall survival (p = 0.63). On multivariate analysis, zinc deficiency (hazard ratio [HR] 1.83, p = 0.040) and prothrombin activity (HR 0.98, p = 0.042) were independent predictors of worse disease-free survival. Subgroup analysis revealed that Zn deficiency was significantly associated with elevated recurrence risk in patients with HCV-related liver disease (HR 3.67, p = 0.013). Conclusions: Preoperative Zn deficiency is an independent predictor of worse DFS after curative hepatectomy. Although further large-scale studies are required to confirm these findings, evaluating preoperative Zn status may help identify patients at high risk of HCC recurrence.
- Open Access
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (17) , e48457
Usefulness and safety of preoperative portal vein embolization in older adults: A STROBE-compliant observational study
With the continuing global trend of population aging, the number of older patients who require hepatectomy for malignant or benign liver diseases is steadily increasing. Postoperative liver failure remains one of the major causes of mortality after major hepatic resection, particularly among patients with limited hepatic reserve. Preoperative portal vein embolization (PVE) has been established as a safe and effective method to increase the future remnant liver volume (RLV), thereby improving postoperative outcomes. However, the regenerative capacity of the aged liver and the clinical benefits of PVE in older patients have not been fully clarified. This study aimed to assess the safety and efficacy of PVE in older patients compared with younger counterparts. We analyzed 113 patients who underwent PVE at Hokkaido University Hospital between 2000 and 2020. Patients were classified into 2 groups: 30 older patients (≥75 years; older group) and 83 younger patients ( Export
- 24 April 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (17) , e48457
Open AccessUsefulness and safety of preoperative portal vein embolization in older adults: A STROBE-compliant observational study
With the continuing global trend of population aging, the number of older patients who require hepatectomy for malignant or benign liver diseases is steadily increasing. Postoperative liver failure remains one of the major causes of mortality after major hepatic resection, particularly among patients with limited hepatic reserve. Preoperative portal vein embolization (PVE) has been established as a safe and effective method to increase the future remnant liver volume (RLV), thereby improving postoperative outcomes. However, the regenerative capacity of the aged liver and the clinical benefits of PVE in older patients have not been fully clarified. This study aimed to assess the safety and efficacy of PVE in older patients compared with younger counterparts. We analyzed 113 patients who underwent PVE at Hokkaido University Hospital between 2000 and 2020. Patients were classified into 2 groups: 30 older patients (≥75 years; older group) and 83 younger patients ( Export
- Open Access
- 1 January 2026
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 12 (1) , cr.26-0567
Emergency Resection for Perforated Small Bowel Metastasis from Primary Lung Cancer During Systemic Therapy: A Case Report
INTRODUCTION: Small bowel metastases from lung cancer may remain clinically occult until serious complications, including obstruction, bleeding, and perforation, occur. We report a case of perforated jejunal metastasis with a synchronous ileal metastasis at high risk of obstruction, identified during emergency surgery while several previously documented extraintestinal lesions had decreased in size.CASE PRESENTATION: A 75-year-old woman with metastatic non-small cell lung carcinoma favoring adenocarcinoma had a programmed death-ligand 1 tumor proportion score of 95% and no targetable alteration on the companion-diagnostic panel. Pembrolizumab monotherapy (200 mg intravenously every 3 weeks) was administered for 4 cycles; no antiangiogenic agent had been administered concurrently or previously. Eleven days after the 4th dose, she developed acute abdominal pain. CT showed focal small bowel wall thickening, adjacent extraluminal air, diffuse bowel edema, and ascites. Emergency surgery revealed a perforated jejunal tumor approximately 20 cm distal to the ligament of Treitz. Systematic examination of the entire small bowel identified a 2nd, nearly circumferential ileal tumor approximately 15 cm proximal to the terminal ileum with marked luminal narrowing; both lesions were resected. Histopathological examination showed metastatic poorly differentiated adenocarcinoma of pulmonary origin. Neither tumor necrosis nor a histological treatment effect was identified, and the non-neoplastic mucosa showed no findings suggestive of immune checkpoint inhibitor-related enteritis. The patient was discharged on POD 19. Pembrolizumab was not resumed. PET-CT on POD 30 demonstrated widespread disease progression, and the patient transitioned to best supportive care. She died on POD 61 without recurrent gastrointestinal perforation, obstruction, or bleeding.CONCLUSIONS: Clinically occult small bowel metastases may present with perforation or impending obstruction during systemic therapy even while previously documented lesions at other sites decrease in size. Because the intestinal lesions were not identifiable before treatment, true discordant progression could not be established. Histopathological findings supported direct tumor-related perforation rather than treatment-induced tumor necrosis or immune-mediated enteritis. Emergency source control and systematic examination of the entire small bowel may identify additional lesions that alter operative management.
- 1 January 2026
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 12 (1) , cr.26-0567
Open AccessEmergency Resection for Perforated Small Bowel Metastasis from Primary Lung Cancer During Systemic Therapy: A Case Report
INTRODUCTION: Small bowel metastases from lung cancer may remain clinically occult until serious complications, including obstruction, bleeding, and perforation, occur. We report a case of perforated jejunal metastasis with a synchronous ileal metastasis at high risk of obstruction, identified during emergency surgery while several previously documented extraintestinal lesions had decreased in size.CASE PRESENTATION: A 75-year-old woman with metastatic non-small cell lung carcinoma favoring adenocarcinoma had a programmed death-ligand 1 tumor proportion score of 95% and no targetable alteration on the companion-diagnostic panel. Pembrolizumab monotherapy (200 mg intravenously every 3 weeks) was administered for 4 cycles; no antiangiogenic agent had been administered concurrently or previously. Eleven days after the 4th dose, she developed acute abdominal pain. CT showed focal small bowel wall thickening, adjacent extraluminal air, diffuse bowel edema, and ascites. Emergency surgery revealed a perforated jejunal tumor approximately 20 cm distal to the ligament of Treitz. Systematic examination of the entire small bowel identified a 2nd, nearly circumferential ileal tumor approximately 15 cm proximal to the terminal ileum with marked luminal narrowing; both lesions were resected. Histopathological examination showed metastatic poorly differentiated adenocarcinoma of pulmonary origin. Neither tumor necrosis nor a histological treatment effect was identified, and the non-neoplastic mucosa showed no findings suggestive of immune checkpoint inhibitor-related enteritis. The patient was discharged on POD 19. Pembrolizumab was not resumed. PET-CT on POD 30 demonstrated widespread disease progression, and the patient transitioned to best supportive care. She died on POD 61 without recurrent gastrointestinal perforation, obstruction, or bleeding.CONCLUSIONS: Clinically occult small bowel metastases may present with perforation or impending obstruction during systemic therapy even while previously documented lesions at other sites decrease in size. Because the intestinal lesions were not identifiable before treatment, true discordant progression could not be established. Histopathological findings supported direct tumor-related perforation rather than treatment-induced tumor necrosis or immune-mediated enteritis. Emergency source control and systematic examination of the entire small bowel may identify additional lesions that alter operative management.
- Open Access
- 1 January 2026
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 12 (1) , cr.26-0452
Presacral Myelolipoma Mimicking Liposarcoma Complicated by Massive Intraoperative Hemorrhage: A Case Report
INTRODUCTION: Myelolipoma is a benign tumor composed of mature adipose tissue and hematopoietic elements. Extra-adrenal lesions can occur in the presacral region and may mimic liposarcoma. Resection of a large presacral tumor can also cause life-threatening hemorrhage. We report a presacral myelolipoma that was difficult to diagnose preoperatively and was complicated by massive intraoperative hemorrhage.CASE PRESENTATION: A 71-year-old woman had an incidentally detected 75 × 75 × 125-mm presacral mass with mixed fatty and solid components on contrast-enhanced CT. MRI showed restricted diffusion, and fluorodeoxyglucose PET/CT showed mild uptake (maximum standardized uptake value, 3.93). No growth occurred over approximately 3 months. Because liposarcoma could not be excluded, the patient chose open resection without biopsy for diagnosis and treatment. During cranial dissection along the anterior sacrum, massive bleeding occurred from the right internal iliac venous system, and systolic blood pressure decreased to 50–60 mmHg. Manual compression was insufficient, and massive transfusion was initiated. Intraoperatively, a vein communicating with the right internal iliac vein was found to enter the tumor, and the main trunk of the right internal iliac vein was ligated near its junction with the right common iliac vein. Persistent bleeding required ligation of a tumor-entering branch of the right internal iliac artery; the arterial main trunk was preserved. Hemostasis was prioritized, and the tumor was removed in 2 pieces; the capsule was disrupted without macroscopic tumor spillage. Diffuse presacral venous plexus bleeding was controlled with electrocautery and oxidized cellulose. Operative time was 3 h 21 min, and blood loss was 4850 mL; 10 units of leukocyte-reduced red blood cells and 6 units of fresh frozen plasma were transfused. Histopathological examination established the diagnosis of myelolipoma. No vascular complications occurred, and contrast-enhanced CT at approximately 1 year showed no residual or recurrent tumor.CONCLUSIONS: Presacral myelolipoma should be considered in the differential diagnosis of fat-containing presacral tumors. In large tumors, the relationship with the internal iliac vessels and presacral venous plexus should be carefully assessed, and adequate blood products, early vascular control, and source-specific hemostatic techniques should be prepared before resection.
- 1 January 2026
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 12 (1) , cr.26-0452
Open AccessPresacral Myelolipoma Mimicking Liposarcoma Complicated by Massive Intraoperative Hemorrhage: A Case Report
INTRODUCTION: Myelolipoma is a benign tumor composed of mature adipose tissue and hematopoietic elements. Extra-adrenal lesions can occur in the presacral region and may mimic liposarcoma. Resection of a large presacral tumor can also cause life-threatening hemorrhage. We report a presacral myelolipoma that was difficult to diagnose preoperatively and was complicated by massive intraoperative hemorrhage.CASE PRESENTATION: A 71-year-old woman had an incidentally detected 75 × 75 × 125-mm presacral mass with mixed fatty and solid components on contrast-enhanced CT. MRI showed restricted diffusion, and fluorodeoxyglucose PET/CT showed mild uptake (maximum standardized uptake value, 3.93). No growth occurred over approximately 3 months. Because liposarcoma could not be excluded, the patient chose open resection without biopsy for diagnosis and treatment. During cranial dissection along the anterior sacrum, massive bleeding occurred from the right internal iliac venous system, and systolic blood pressure decreased to 50–60 mmHg. Manual compression was insufficient, and massive transfusion was initiated. Intraoperatively, a vein communicating with the right internal iliac vein was found to enter the tumor, and the main trunk of the right internal iliac vein was ligated near its junction with the right common iliac vein. Persistent bleeding required ligation of a tumor-entering branch of the right internal iliac artery; the arterial main trunk was preserved. Hemostasis was prioritized, and the tumor was removed in 2 pieces; the capsule was disrupted without macroscopic tumor spillage. Diffuse presacral venous plexus bleeding was controlled with electrocautery and oxidized cellulose. Operative time was 3 h 21 min, and blood loss was 4850 mL; 10 units of leukocyte-reduced red blood cells and 6 units of fresh frozen plasma were transfused. Histopathological examination established the diagnosis of myelolipoma. No vascular complications occurred, and contrast-enhanced CT at approximately 1 year showed no residual or recurrent tumor.CONCLUSIONS: Presacral myelolipoma should be considered in the differential diagnosis of fat-containing presacral tumors. In large tumors, the relationship with the internal iliac vessels and presacral venous plexus should be carefully assessed, and adequate blood products, early vascular control, and source-specific hemostatic techniques should be prepared before resection.
- 10 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (7) , e70230
Impact of Frailty on Physical Activity in the Postoperative Period After Liver Transplant Surgery: Pilot Study Using Fitbit Watch
Introduction: Robust physical activity after liver transplant (LT) is an important determinant of long‐term health. This pilot study aimed to evaluate whether a physical activity monitor (PAM) can be employed to monitor postoperative physical activity levels after LT.Methods: Adult patients undergoing LT were screened for inclusion. Several frailty tests, including the liver frailty index, were performed in the preoperative and postoperative periods. All patients were provided with Fitbit Inspire 2 watches to measure biophysical data and were instructed to wear them continuously for 30–60 postoperative days (POD).Results: Thirty‐five patients were enrolled in the study. There was a negative linear correlation between age and the average daily steps during POD 1–30 and POD 31–60 after LT (r = −0.52, P = 0.001; r = −0.36, P = 0.044, respectively). In addition, longer hospital length of stay was negatively associated with daily steps during POD 1–30 and POD 31–60 (r = −0.43, P = 0.01; r = −0.50, P = 0.002, respectively). The majority of patients (89%) reported a medical benefit from using the PAM in the postoperative period.Conclusion: This is the first study to demonstrate the feasibility and utility of providing wearable devices to measure patient physical activity after LT.
- 10 July 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (7) , e70230
Impact of Frailty on Physical Activity in the Postoperative Period After Liver Transplant Surgery: Pilot Study Using Fitbit Watch
Introduction: Robust physical activity after liver transplant (LT) is an important determinant of long‐term health. This pilot study aimed to evaluate whether a physical activity monitor (PAM) can be employed to monitor postoperative physical activity levels after LT.Methods: Adult patients undergoing LT were screened for inclusion. Several frailty tests, including the liver frailty index, were performed in the preoperative and postoperative periods. All patients were provided with Fitbit Inspire 2 watches to measure biophysical data and were instructed to wear them continuously for 30–60 postoperative days (POD).Results: Thirty‐five patients were enrolled in the study. There was a negative linear correlation between age and the average daily steps during POD 1–30 and POD 31–60 after LT (r = −0.52, P = 0.001; r = −0.36, P = 0.044, respectively). In addition, longer hospital length of stay was negatively associated with daily steps during POD 1–30 and POD 31–60 (r = −0.43, P = 0.01; r = −0.50, P = 0.002, respectively). The majority of patients (89%) reported a medical benefit from using the PAM in the postoperative period.Conclusion: This is the first study to demonstrate the feasibility and utility of providing wearable devices to measure patient physical activity after LT.
- Open Access
- 19 January 2024
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 8 (3) , 383-393
Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes
Background: We aimed to identify the characteristics of new‐onset diabetes after liver transplantation (LT) (NODAT) and investigate its impacts on post‐transplant outcomes.Methods: Adult LT patients between 2014 and 2020 who used tacrolimus as initial immunosuppression and survived 3 months at least were evaluated. Patients who developed NODAT within 3 months after LT were classified as NODAT group. Also, patients were further classified as history of diabetes before LT (PHDBT) and non‐diabetes (ND) groups. Patient characteristics, post‐LT outcomes, and cardiovascular and/or pulmonary complications were compared.Results: A total of 83, 225, and 263 patients were classified into NODAT, PHDBT, and ND groups. The proportion of cholestatic liver disease and rejection within 90 days were higher in NODAT group. Mean serum tacrolimus concentration trough level in the first week after LT was 7.12, 6.12, and 6.12 ng/mL (p < 0.001). Duration of corticosteroids was significantly longer in NODAT compared to PHDBD or ND (416, 289, and 228 days, p < 0.001). Three‐year graft and patient survival were significantly worse in NODAT than ND (80.5% vs. 95.0%, p < 0.001: 82.0% vs. 95.4%, p < 0.001) but similar to PHDBT. Adjusted risks of 3‐year graft loss and patient death using Cox regression analysis were significantly higher in NODAT compared to ND (adjusted hazard ratio [aHR] 3.41, p = 0.004; aHR 3.61, p = 0.004). Incidence rates of cardiovascular or pulmonary complications after LT in NODAT were significantly higher than ND but similar to PHDBT.Conclusion: Higher initial tacrolimus concentration and early rejection might be risk factors for NODAT. NODAT was associated with worse post‐transplant outcomes.
- 19 January 2024
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 8 (3) , 383-393
Open AccessClinical characteristics of new‐onset diabetes after liver transplantation and outcomes
Background: We aimed to identify the characteristics of new‐onset diabetes after liver transplantation (LT) (NODAT) and investigate its impacts on post‐transplant outcomes.Methods: Adult LT patients between 2014 and 2020 who used tacrolimus as initial immunosuppression and survived 3 months at least were evaluated. Patients who developed NODAT within 3 months after LT were classified as NODAT group. Also, patients were further classified as history of diabetes before LT (PHDBT) and non‐diabetes (ND) groups. Patient characteristics, post‐LT outcomes, and cardiovascular and/or pulmonary complications were compared.Results: A total of 83, 225, and 263 patients were classified into NODAT, PHDBT, and ND groups. The proportion of cholestatic liver disease and rejection within 90 days were higher in NODAT group. Mean serum tacrolimus concentration trough level in the first week after LT was 7.12, 6.12, and 6.12 ng/mL (p < 0.001). Duration of corticosteroids was significantly longer in NODAT compared to PHDBD or ND (416, 289, and 228 days, p < 0.001). Three‐year graft and patient survival were significantly worse in NODAT than ND (80.5% vs. 95.0%, p < 0.001: 82.0% vs. 95.4%, p < 0.001) but similar to PHDBT. Adjusted risks of 3‐year graft loss and patient death using Cox regression analysis were significantly higher in NODAT compared to ND (adjusted hazard ratio [aHR] 3.41, p = 0.004; aHR 3.61, p = 0.004). Incidence rates of cardiovascular or pulmonary complications after LT in NODAT were significantly higher than ND but similar to PHDBT.Conclusion: Higher initial tacrolimus concentration and early rejection might be risk factors for NODAT. NODAT was associated with worse post‐transplant outcomes.
- 15 November 2023
- Published by Wiley in Clinical Transplantation
- Vol. 38 (1) , e15190
Post‐transplant outcomes and financial burden of donation after circulatory death donor liver transplant after the implementation of acuity circle policy
Background: After implementation of the Acuity Circles (AC) allocation policy, use of DCD liver grafts has increased in the United States.Methods: We evaluated the impact of AC on rates of DCD‐liver transplants (LT), their outcomes, and medical costs in a single practice. Adult LT patients were classified into three eras: Era 1 (pre‐AC, 1/01/2015–12/31/2017); Era 2 (late pre‐AC era, 1/01/2018–02/03/2020); and Era 3 (AC era, 05/10/2020–09/30/2021).Results: A total of 520 eligible LTs were performed; 87 were DCD, and 433 were DBD. With each successive era, the proportion of DCD increased (Era 1: 11%; Era 2: 20%; Era 3: 24%; p < .001). DCD recipients had longer ICU stays, higher re‐admission/re‐operation rates, and higher incidence of ischemic cholangiopathy compared to those with DBD. Direct, surgical, and ICU costs during first admission were higher with DCD than DBD (+8.0%, p < .001; +4.2%, p < .001; and +33.3%, p = .001). DCD‐related costs increased after Era 1 (Direct: +4.9% [Era 2 vs. 1] and +12.4% [Era 3 vs. 1], p = .04; Surgical: +17.7% and +21.7%, p < .001). In the AC era, there was a significantly higher proportion of donors ≥50 years, and more national organ sharing. Compared to DCD from donors p = .01; +9.5%, p = .01; +84.6%, p = .03).Conclusions: The proportion of DCD‐LT, especially from older donors, has increased after the implementation of AC policies. These changes are likely to be associated with higher costs in the AC era.
- 15 November 2023
- Published by Wiley in Clinical Transplantation
- Vol. 38 (1) , e15190
Post‐transplant outcomes and financial burden of donation after circulatory death donor liver transplant after the implementation of acuity circle policy
Background: After implementation of the Acuity Circles (AC) allocation policy, use of DCD liver grafts has increased in the United States.Methods: We evaluated the impact of AC on rates of DCD‐liver transplants (LT), their outcomes, and medical costs in a single practice. Adult LT patients were classified into three eras: Era 1 (pre‐AC, 1/01/2015–12/31/2017); Era 2 (late pre‐AC era, 1/01/2018–02/03/2020); and Era 3 (AC era, 05/10/2020–09/30/2021).Results: A total of 520 eligible LTs were performed; 87 were DCD, and 433 were DBD. With each successive era, the proportion of DCD increased (Era 1: 11%; Era 2: 20%; Era 3: 24%; p < .001). DCD recipients had longer ICU stays, higher re‐admission/re‐operation rates, and higher incidence of ischemic cholangiopathy compared to those with DBD. Direct, surgical, and ICU costs during first admission were higher with DCD than DBD (+8.0%, p < .001; +4.2%, p < .001; and +33.3%, p = .001). DCD‐related costs increased after Era 1 (Direct: +4.9% [Era 2 vs. 1] and +12.4% [Era 3 vs. 1], p = .04; Surgical: +17.7% and +21.7%, p < .001). In the AC era, there was a significantly higher proportion of donors ≥50 years, and more national organ sharing. Compared to DCD from donors p = .01; +9.5%, p = .01; +84.6%, p = .03).Conclusions: The proportion of DCD‐LT, especially from older donors, has increased after the implementation of AC policies. These changes are likely to be associated with higher costs in the AC era.
- 21 March 2023
- Published by Elsevier in Transplantation Proceedings
- Vol. 55 (4) , 1016-1020
Hypothermic Machine Perfusion with Hydrogen Gas Reduces Focal Injury in Rat Livers but Fails to Restore Organ Function
- 21 March 2023
- Published by Elsevier in Transplantation Proceedings
- Vol. 55 (4) , 1016-1020
Hypothermic Machine Perfusion with Hydrogen Gas Reduces Focal Injury in Rat Livers but Fails to Restore Organ Function
- 10 December 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1422-1423
ASO Visual Abstract: Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients With Hepatocellular Carcinoma
- 10 December 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1422-1423
ASO Visual Abstract: Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients With Hepatocellular Carcinoma
- 25 November 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1408-1419
Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients with Hepatocellular Carcinoma
Liver transplant (LT) candidates with hepatocellular carcinoma (HCC) often receive cancer treatment before transplant. We investigated the impact of pre-tr
- 25 November 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1408-1419
Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients with Hepatocellular Carcinoma
Liver transplant (LT) candidates with hepatocellular carcinoma (HCC) often receive cancer treatment before transplant. We investigated the impact of pre-tr